15 Bibliography - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/2465/15/15... · 2012-06-20 · 15 Bibliography Reference List 1. Hultgren HN, Marticorena EA. High altitude

15 BibliographyReference List

1. Hultgren HN, Marticorena EA. High altitude pulmonary edema. Epidemiologic observations in Peru. Chest 1978; 74(4):372-376.

2. Falk R. What is a gene? Stud Hist Philos Sci 1986; 17(2):133-173.

3. Gerstein MB, Bruce C, Rozowsky JS et al. What is a gene, post-ENCODE? History and updated definition. Genome Res 2007; 17(6):669-681.

4. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57(2):313-370.

5. Wolf G. Novel aspects of the renin-angiotensin-aldosterone-system. Front Biosci 2008; 13:4993-5005.

6. Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 2007; 13(8 Suppl B):9-20.

7. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266(23):15377-15383.

8. Waeber B, Juillerat-Jeanneret L, Aubert JF, Schapira M, Nussberger J, Brunner HR. Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors. Br J Clin Pharmacol 1989; 27 Suppl 2:175S-180S.

9. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92(6):1387-1388.

10. Reneland R, Haenni A, Andersson PE, Andren B, Lithell H. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men. Blood Press 1999; 8(1):16-22.

11. Yosipiv IV, Dipp S, el-Dahr SS. Ontogeny of somatic angiotensin-converting enzyme. Hypertension 1994; 23(3):369-374.

12. Kanazawa H, Okamoto T, Hirata K, Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162(4 Pt 1):1235-1238.

13. Natesh R, Schwager SL, Sturrock ED, Acharya KR. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003; 421(6922):551-554.

14. Arndt JW, Hao B, Ramakrishnan V, Cheng T, Chan SI, Chan MK. Crystal structure of a novel carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. Structure 2002; 10(2):215-224.

15. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51(1):197-205.

16. Rigat B, Hubert C, henc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86(4):1343-1346.

17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20(6):1433.

18. McKenzie CA, Abecasis GR, Keavney B et al. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 2001; 10(10):1077-1084.

19. Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999; 87(4):1313-1316.

20. Montgomery HE, Marshall R, Hemingway H et al. Human gene for physical performance. Nature 1998; 393(6682):221-222.

21. Qadar Pasha MA, Khan AP, Kumar R et al. Angiotensin converting enzyme insertion allele in relation to high altitude adaptation. Ann Hum Genet 2001; 65(Pt 6):531-536.

22. Kumar R, Qadar Pasha MA, Khan AP et al. Association of high-altitude systemic hypertension with the deletion allele-of the angiotensin-converting enzyme (ACE) gene. Int J Biometeorol 2003; 48(1):10-14.

23. Charu R, Stobdan T, Ram RB, Khan AP, Qadar Pasha MA, Norboo T, Afrin F. Susceptibility to high altitude pulmonary oedema: role of ACE and ET-1 polymorphisms. Thorax 2006; 61(11):1011-1012.

24. Patel S, Woods DR, Macleod NJ, Brown A, Patel KR, Montgomery HE, Peacock AJ. Angiotensin-converting enzyme genotype and the ventilatory response to exertional hypoxia. Eur Respir J 2003; 22(5):755-760.

25. Rupert JL, Kidd KK, Norman LE, Monsalve MV, Hochachka PW, Devine DV. Genetic polymorphisms in the Renin-Angiotensin system in high-altitude and low-altitude Native American populations. Ann Hum Genet 2003; 67(Pt 1):17-25.

26. Koehle MS, Wang P, Guenette JA, Rupert JL. No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m. High Alt Med Biol 2006; 7(4):281-289.

27. Morrell NW, Sarybaev AS, Alikhan A, Mirrakhimov MM, Aldashev AA. ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet 1999; 353(9155):814.

28. Aldashev AA, Sarybaev AS, Sydykov AS et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am J Respir Crit Care Med 2002; 166(10):1396-1402.

29. Krege JH, John SW, Langenbach LL et al. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995; 375(6527):146-148.

30. Ramaraj P, Kessler SP, Colmenares C, Sen GC. Selective restoration of male fertility in mice lacking angiotensin-converting enzymes by sperm-specific expression of the testicular isozyme. J Clin Invest 1998; 102(2):371-378.

31. Cole JM, Xiao H, Adams JW, Disher KM, Zhao H, Bernstein KE. New approaches to genetic manipulation of mice: tissue-specific expression of ACE. Am J Physiol Renal Physiol 2003; 284(4):F599-F607.

32. Doolittle RF. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family1. Science 1983; 222(4622):417-419.

33. Clauser E, Gaillard I, Wei L, Corvol P. Regulation of angiotensinogen gene2. Am J Hypertens 1989; 2(5 Pt 1):403-410.

34. Hoj NA, Knudsen F. Angiotensinogen is an acute-phase protein in man1. Scand J Clin Lab Invest 1987; 47(2):175-178.

35. Gaillard I, Clauser E, Corvol P. Structure of human angiotensinogen gene3. DNA 1989; 8(2):87-99.

36. Gaillard-Sanchez I, Mattei MG, Clauser E, Corvol P. Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene. Hum Genet 1990; 84(4):341-343.

37. Isa MN, Boyd E, Morrison N, Harrap S, Clauser E, Connor JM. Assignment of the human angiotensinogen gene to chromosome 1q42-q43 by nonisotopic in situ hybridization [corrected]. Genomics 1990; 8(3):598-600.

38. Abonia JP, Abel KJ, Eddy RL, Elliott RW, Chapman VM, Shows TB, Gross KW. Linkage of Agt and Actsk-1 to distal mouse chromosome 8 loci: a new conserved linkage. Mamm Genome 1993; 4(1):25-32.

39. Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71(1):169-180.

40. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95(3):948-953.

41. Danser AH, Derkx FH, Hense HW, Jeunemaitre X, Riegger GA, Schunkert H. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998; 16(12 Pt 2):1879-1883.

42. Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Gupta M, Javed S, Pasha MQ. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension. J Hypertens 2008; 26(6):1094-1101.

43. Inoue I, Nakajima T, Williams CS et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99(7):1786-1797.

44. Schunkert H, Hense HW, Gimenez-Roqueplo AP, Stieber J, Keil U, Riegger GA, Jeunemaitre X. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort8. Hypertension 1997; 29(2):628-633.

45. Pereira TV, Nunes AC, Rudnicki M, Yamada Y, Pereira AC, Krieger JE. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T? Hypertension 2008; 51(3):778-783.

46. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23(7):1269-1275.

47. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases11. Circ Res 1997; 80(5):607-616.

48. Allen AM, Zhuo J, Mendelsohn FA. Localization of angiotensin AT1 and AT2 receptors2. J Am Soc Nephrol 1999; 10 Suppl 11:S23-S29.

49. Sadoshima J. Cytokine actions of angiotensin II2. Circ Res 2000; 86(12):1187-1189.

50. Gemmill RM, Drabkin HA. Report of the Second International Workshop on Human Chromosome 3 mapping3. Cytogenet Cell Genet 1991; 57(4):162-166.

51. Guo DF, Furuta H, Mizukoshi M, Inagami T. The genomic organization of human angiotensin II type 1 receptor9. Biochem Biophys Res Commun 1994; 200(1):313-319.

52. Bonnardeaux A, Davies E, Jeunemaitre X et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24(1):63-69.

53. Pende A, Giacche M, Castigliola L et al. Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA1. Biochem Biophys Res Commun 1999; 266(2):609-614.

54. Martin MM, Buckenberger JA, Jiang J et al. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 2007; 282(33):24262-24269.

55. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction1. Lancet 1994; 344(8927):910-913.

56. Jones A, Dhamrait SS, Payne JR et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003; 42(4):500-506.

57. Bonnardeaux A, Davies E, Jeunemaitre X et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension3. Hypertension 1994; 24(1):63-69.

58. Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension1. Clin Genet 1997; 51(1):31-34.

59. Castellano M, Muiesan ML, Beschi M et al. Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure2. Hypertension 1996; 28(6):1076-1080.

60. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension2. J Hypertens 1997; 15(12 Pt 1):1385-1388.

61. Hotta J, Hanaoka M, Droma Y, Katsuyama Y, Ota M, Kobayashi T. Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest 2004; 126(3):825-830.

62. Chassagne C, Beatty BG, Meloche S. Assignment of the human angiotensin II type 2 receptor gene (AGTR2) to chromosome Xq22-q23 by fluorescence in situ hybridization. Genomics 1995; 25(2):601-603.

63. Martin MM, Elton TS. The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun 1995; 209(2):554-562.

64. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996; 93(1):156-160.

65. Nishimura H, Yerkes E, Hohenfellner K et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999; 3(1):1-10.

66. Akishita M, Iwai M, Wu L, Zhang L, Ouchi Y, Dzau VJ, Horiuchi M. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 2000; 102(14):1684-1689.

67. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001; 104(3):346-351.

68. Wu L, Iwai M, Nakagami H et al. Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol 2002; 22(1):49-54.

69. Brede M, Roell W, Ritter O et al. Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension 2003; 42(6):1177-1182.

70. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95(2):651-657.

71. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T. Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation 2002; 106(17):2244-2249.

72. Oishi Y, Ozono R, Yano Y et al. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension 2003; 41(3 Pt 2):814-818.

73. Kainulainen K, Perola M, Terwilliger J et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 1999; 33(3):844-849.

74. Jin JJ, Nakura J, Wu Z et al. Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 2003; 26(7):547-552.

75. Zhang Y, Zhang KX, Wang GL, Huang W, Zhu DL. Angiotensin II type 2 receptor gene polymorphisms and essential hypertension. Acta Pharmacol Sin 2003; 24(11):1089-1093.

76. Herrmann SM, Nicaud V, Schmidt-Petersen K et al. Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. Eur J Heart Fail 2002; 4(6):707-712.

77. Zhang M, Ma H, Wang BS, Zhao YZ. Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension. Heart Vessels 2006; 21(2):95-101.

78. Orlowska-Baranowska E, Placha G, Baranowski R, Michalek P, Gora J, Gaciong Z, Stepinska J. Can angiotensin II +1675 G/A type 2 receptor gene polymorphism be a marker of left ventricular hypertrophy in patients with aortic stenosis? J Heart Valve Dis 2007; 16(5):495-503.

79. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk of complex disease. Curr Opin Genet Dev 2008; 18(3):257-263.

80. Baker PT. Human adaptation to high altitude. Science 1969; 163(872):1149-1156.

81. Beall CM. Detecting natural selection in high-altitude human populations. Respir Physiol Neurobiol 2007; 158(2-3):161-171.

82. Stobdan T, Karar J, Pasha MA. High altitude adaptation: genetic perspectives. High Alt Med Biol 2008; 9(2):140-147.

83. Brutsaert TD. Population genetic aspects and phenotypic plasticity of ventilatory responses in high altitude natives. Respir Physiol Neurobiol 2007; 158(2-3):151-160.

84. Beall CM, Decker MJ, Brittenham GM, Kushner I, Gebremedhin A, Strohl KP. An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proc Natl Acad Sci U S A 2002; 99(26):17215-17218.

85. Ahsan A, Charu R, Pasha MA et al. eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax 2004; 59(11):1000-1002.

86. Ahsan A, Mohd G, Norboo T, Baig MA, Pasha MA. Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema. Chest 2006; 130(5):1511-1519.

87. Beall CM. Tibetan and Andean contrasts in adaptation to high-altitude hypoxia. Adv Exp Med Biol 2000; 475:63-74.

88. Beall CM. Tibetan and Andean patterns of adaptation to high-altitude hypoxia. Hum Biol 2000; 72(1):201-228.

89. Rupert JL, Hochachka PW. Genetic approaches to understanding human adaptation to altitude in the Andes. J Exp Biol 2001; 204(Pt 18):3151-3160.

90. Groves BM, Droma T, Sutton JR et al. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J Appl Physiol 1993; 74(1):312-318.

91. Erzurum SC, Ghosh S, Janocha AJ et al. Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A 2007; 104(45):17593-17598.

92. Beall CM, Brittenham GM, Strohl KP et al. Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol 1998; 106(3):385-400.

93. Winslow RM, Chapman KW, Gibson CC et al. Different hematologic responses to hypoxia in Sherpas and Quechua Indians. J Appl Physiol 1989; 66(4):1561-1569.

94. Zhuang J, Droma T, Sun S et al. Hypoxic ventilatory responsiveness in Tibetan compared with Han residents of 3,658 m. J Appl Physiol 1993; 74(1):303-311.

95. Leon-Velarde F, McCullough RG, McCullough RE, Reeves JT. Proposal for scoring severity in chronic mountain sickness (CMS). Background and conclusions of the CMS Working Group. Adv Exp Med Biol 2003; 543:339-354.

96. Niermeyer S, Yang P, Shanmina, Drolkar, Zhuang J, Moore LG. Arterial oxygen saturation in Tibetan and Han infants born in Lhasa, Tibet. N Engl J Med 1995; 333(19):1248-1252.

97. Wood S, Norboo T, Lilly M, Yoneda K, Eldridge M. Cardiopulmonary function in high altitude residents of Ladakh. High Alt Med Biol 2003; 4(4):445-454.

98. Gupta ML, Rao KS, Anand IS, Banerjee AK, Boparai MS. Lack of smooth muscle in the small pulmonary arteries of the native Ladakhi. Is the Himalayan highlander adapted? Am Rev Respir Dis 1992; 145(5):1201-1204.

99. Brutsaert TD, Soria R, Caceres E, Spielvogel H, Haas JD. Effect of developmental and ancestral high altitude exposure on chest morphology and pulmonary function in Andean and European/North American natives. Am J Hum Biol 1999; 11(3):383-395.

100. Moore LG, Shriver M, Bemis L et al. Maternal adaptation to high-altitude pregnancy: an experiment of nature--a review. Placenta 2004; 25 Suppl A:S60-S71.

101. Moore LG, Shriver M, Bemis L, Vargas E. An evolutionary model for identifying genetic adaptation to high altitude. Adv Exp Med Biol 2006; 588:101-118.

102. Malhotra MS, Selvamurthy W, Purkayastha SS, Mukherjee AK, Mathew L, Dua GL. Responses of the autonomic nervous system during acclimatization tp high altitude in man. Aviat Space Environ Med 1976; 47(10):1076-1079.

103. Wolfel EE, Selland MA, Mazzeo RS, Reeves JT. Systemic hypertension at 4,300 m is related to sympathoadrenal activity. J Appl Physiol 1994; 76(4):1643-1650.

104. Marshall JM. Peripheral chemoreceptors and cardiovascular regulation. Physiol Rev 1994; 74(3):543-594.

105. Reis DJ, Golanov EV, Ruggiero DA, Sun MK. Sympatho-excitatory neurons of the rostral ventrolateral medulla are oxygen sensors and essential elements in the tonic and reflex control of the systemic and cerebral circulations. J Hypertens Suppl 1994; 12(10):S159-S180.

106. Duplain H, Vollenweider L, Delabays A, Nicod P, Bartsch P, Scherrer U. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 1999; 99(13):1713-1718.

107. Calbet JA. Oxygen tension and content in the regulation of limb blood flow. Acta Physiol Scand 2000; 168(4):465-472.

108. Rowell LB, Johnson DG, Chase PB, Comess KA, Seals DR. Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans. J Appl Physiol 1989; 66(4):1736-1743.

109. Leuenberger U, Gleeson K, Wroblewski K, Prophet S, Zelis R, Zwillich C, Sinoway L. Norepinephrine clearance is increased during acute hypoxemia in humans. Am J Physiol 1991; 261(5 Pt 2):H1659-H1664.

110. Hilton R, Eichholtz F. The influence of chemical factors on the coronary circulation. J Physiol 1925; 59(6):413-425.

111. Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164(4):597-601.

112. Imadojemu VA, Gleeson K, Gray KS, Sinoway LI, Leuenberger UA. Obstructive apnea during sleep is associated with peripheral vasoconstriction. Am J Respir Crit Care Med 2002; 165(1):61-66.

113. Calbet JA. Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. J Physiol 2003; 551(Pt 1):379-386.

114. Mirrakhimov MM, Winslow RM: The cardiovascular system at high altitude; in: Fregley MJ, Blatties CM, (eds): Handbook of Physiology. New York, Oxford University Press, 1996.

115. Lahiri S. Historical perspectives of cellular oxygen sensing and responses to hypoxia. J Appl Physiol 2000; 88(4):1467-1473.

116. Mazzeo RS, Wolfel EE, Butterfield GE, Reeves JT. Sympathetic response during 21 days at high altitude (4,300 m) as determined by urinary and arterial catecholamines. Metabolism 1994; 43(10):1226-1232.

117. Milledge JS, Catley DM, Ward MP, Williams ES, Clarke CR. Renin-aldosterone and angiotensin-converting enzyme during prolonged altitude exposure. J Appl Physiol 1983; 55(3):699-702.

118. Keynes RJ, Smith GW, Slater JD et al. Renin and aldosterone at high altitude in man. J Endocrinol 1982; 92(1):131-140.

119. Morrell NW, Morris KG, Stenmark KR. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 1995; 269(4 Pt 2):H1186-H1194.

120. Hanna JM. Climate, altitude, and blood pressure. Hum Biol 1999; 71(4):553-582.

121. Clegg EJ, Jeffries DJ, Harrison GA. Determinants of blood pressure at high and low altitudes in Ethiopia. Proc R Soc Lond B Biol Sci 1976; 194(1114):63-82.

122. Tripathy V, Gupta R. Blood pressure variation among Tibetans at different altitudes. Ann Hum Biol 2007; 34(4):470-483.

123. Mirrakhimov MM: Biological and physiological characteristics of the high altitude natives of Tien Shan andthe Pamirs.; The biology of high-altitude peoples. New York, Cambridge University Press, 1978, pp 299-316.

124. Beall CM, Gebremedhin A, Brittenham GM, Decker MJ, Shamebo M. Blood pressure variation among Ethiopians on the Simien Plateau. Ann Hum Biol 1997; 24(4):333-342.

125. Ruiz L, Penaloza D. Altitude and hypertension. Mayo Clin Proc 1977; 52(7):442-445.

126. Maddocks I, Vines AP. The influence of chronic infection on blood-pressure in New Guinea males. Lancet 1966; 2(7457):262-264.

127. Leon-Velarde F, Sanchez J, Bigard AX, Brunet A, Lesty C, Monge C. High altitude tissue adaptation in Andean coots: capillarity, fibre area, fibre type and enzymatic activities of skeletal muscle. J Comp Physiol [B] 1993; 163(1):52-58.

128. Sun SF. Epidemiology of hypertension on the Tibetan Plateau. Hum Biol 1986; 58(4):507-515.

129. Smith C. Blood pressures of Sherpa men in modernizing Nepal. Am J Hum Biol 1999; 11(4):469-479.

130. Lifton RP. Molecular genetics of human blood pressure variation. Science 1996; 272(5262):676-680.

131. Rajput C, Makhijani K, Norboo T, Afrin F, Sharma M, Pasha ST, Pasha MA. CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake. J Hypertens 2005; 23(1):79-86.

132. Monge CC, Whittembury J. Chronic mountain sickness. Johns Hopkins Med J 1976; 139 SUPPL:87-89.

133. Leon-Velarde F, Ramos MA, Hernandez JA et al. The role of menopause in the development of chronic mountain sickness. Am J Physiol 1997; 272(1 Pt 2):R90-R94.

134. Pei SX, Chen XJ, Si Ren BZ et al. Chronic mountain sickness in Tibet. Q J Med 1989; 71(266):555-574.

135. Wu TY. Chronic mountain sickness on the Qinghai-Tibetan plateau. Chin Med J (Engl ) 2005; 118(2):161-168.

136. Xing G, Qualls C, Huicho L et al. Adaptation and mal-adaptation to ambient hypoxia; Andean, Ethiopian and Himalayan patterns. PLoS ONE 2008; 3(6):e2342.

137. Norboo T, Saiyed HN, Angchuk PT et al. Mini review of high altitude health problems in Ladakh. Biomed Pharmacother 2004; 58(4):220-225.

138. Monge C, Arregui A, Leon-Velarde F. Pathophysiology and epidemiology of chronic mountain sickness. Int J Sports Med 1992; 13 Suppl 1:S79-S81.

139. Monge C, Lozano R, Whittembury J. Effect of blood-letting on chronic mountain sickness. Nature 1965; 207(998):770.

140. Penaloza D, Sime F. Chronic cor pulmonale due to loss of altitude acclimatization (chronic mountain sickness). Am J Med 1971; 50(6):728-743.

141. Gleadle JM, Ratcliffe PJ. Hypoxia and the regulation of gene expression. Mol Med Today 1998; 4(3):122-129.

142. Cerretelli P. Limiting factors to oxygen transport on Mount Everest. J Appl Physiol 1976; 40(5):658-667.

143. Boero JA, Ascher J, Arregui A, Rovainen C, Woolsey TA. Increased brain capillaries in chronic hypoxia. J Appl Physiol 1999; 86(4):1211-1219.

144. Reeves JT, Groves BM, Sutton JR et al. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol 1987; 63(2):531-539.

145. Yilmaz M, Aydin A, Karasu Z, Gunsar F, Ozutemiz O. Risk factors associated with changes in oxygenation and pulse rate during colonoscopy. Turk J Gastroenterol 2002; 13(4):203-208.

146. Asano K, Mazzeo RS, McCullough RE, Wolfel EE, Reeves JT. Relation of sympathetic activation to ventilation in man at 4300 m altitude. Aviat Space Environ Med 1997; 68(2):104-110.

147. Koller EA, Drechsel S, Hess T, Macherel P, Boutellier U. Effects of atropine and propranolol on the respiratory, circulatory, and ECG responses to high altitude in man. Eur J Appl Physiol Occup Physiol 1988; 57(2):163-172.

148. Mazzeo RS, Child A, Butterfield GE, Mawson JT, Zamudio S, Moore LG. Catecholamine response during 12 days of high-altitude exposure (4, 300 m) in women. J Appl Physiol 1998; 84(4):1151-1157.

149. Passino C, Bernardi L, Spadacini G et al. Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents. Clin Sci (Lond) 1996; 91 Suppl:81-83.

150. Hoppeler H, Vogt M. Hypoxia training for sea-level performance. Training high-living low. Adv Exp Med Biol 2001; 502:61-73.

151. Hoppeler H, Klossner S, Vogt M. Training in hypoxia and its effects on skeletal muscle tissue. Scand J Med Sci Sports 2008; 18 Suppl 1:38-49.

152. Gelfi C, De PS, Ripamonti M et al. New aspects of altitude adaptation in Tibetans: a proteomic approach. FASEB J 2004; 18(3):612-614.

153. Terrados N, Jansson E, Sylven C, Kaijser L. Is hypoxia a stimulus for synthesis of oxidative enzymes and myoglobin? J Appl Physiol 1990; 68(6):2369-2372.

154. Basnyat B, Murdoch DR. High-altitude illness. Lancet 2003; 361(9373):1967-1974.

155. Basnyat B. High altitude cerebral and pulmonary edema. Travel Med Infect Dis 2005; 3(4):199-211.

156. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001; 345(2):107-114.

157. Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976; 2(7996):1149-1155.

158. Roach RC, Bartsch P, Hackett P, Oelz O: Lake Louise acute mountain sickness scoring system.; in: Sutton JR, Coates G, Houston CH, (eds): Hypoxia and molecular medicine. Burlington, Queen City Press, 1993, pp 272-274.

159. Hackett PH. High altitude cerebral edema and acute mountain sickness. A pathophysiology update. Adv Exp Med Biol 1999; 474:23-45.

160. Hultgren HN. High-altitude pulmonary edema: current concepts. Annu Rev Med 1996; 47:267-284.

161. Hultgren H, Spickard W. Medical experiences in Peru. 1960. Wilderness Environ Med 1998; 9(3):166-185.

162. Houston CS. Acute pulmonary edema of high altitude. N Engl J Med 1960; 263:478-480.

163. Hultgren HN, LOPEZ CE, LUNDBERG E, MILLER H. PHYSIOLOGIC STUDIES OF PULMONARY EDEMA AT HIGH ALTITUDE. Circulation 1964; 29:393-408.

164. Bartsch P, Mairbaurl H, Swenson ER, Maggiorini M. High altitude pulmonary oedema. Swiss Med Wkly 2003; 133(27-28):377-384.

165. Bartsch P, Mairbaurl H, Maggiorini M, Swenson ER. Physiological aspects of high-altitude pulmonary edema. J Appl Physiol 2005; 98(3):1101-1110.

166. Hultgren HN, Grover RF, Hartley LH. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation 1971; 44(5):759-770.

167. Bartsch P, Maggiorini M, Schobersberger W et al. Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol 1991; 71(1):136-143.

168. Schoene RB, Swenson ER, Pizzo CJ et al. The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema. J Appl Physiol 1988; 64(6):2605-2613.

169. Tsukimoto K, Mathieu-Costello O, Prediletto R, Elliott AR, West JB. Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol 1991; 71(2):573-582.

170. Costello ML, Mathieu-Costello O, West JB. Stress failure of alveolar epithelial cells studied by scanning electron microscopy. Am Rev Respir Dis 1992; 145(6):1446-1455.

171. Swenson ER, Maggiorini M, Mongovin S, Gibbs JS, Greve I, Mairbaurl H, Bartsch P. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 2002; 287(17):2228-2235.

172. Kleger GR, Bartsch P, Vock P, Heilig B, Roberts LJ, Ballmer PE. Evidence against an increase in capillary permeability in subjects exposed to high altitude. J Appl Physiol 1996; 81(5):1917-1923.

173. Sartori C, Allemann Y, Duplain H et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002; 346(21):1631-1636.

174. Litvan J, Briva A, Wilson MS, Budinger GR, Sznajder JI, Ridge KM. Beta-adrenergic receptor stimulation and adenoviral overexpression of superoxide dismutase prevent the hypoxia-mediated decrease in Na,K-ATPase and alveolar fluid reabsorption. J Biol Chem 2006; 281(29):19892-19898.

175. Dada LA, Chandel NS, Ridge KM, Pedemonte C, Bertorello AM, Sznajder JI. Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest 2003; 111(7):1057-1064.

176. Barry PW, Pollard AJ. Altitude illness. BMJ 2003; 326(7395):915-919.

177. Hanaoka M, Kubo K, Yamazaki Y et al. Association of high-altitude pulmonary edema with the major histocompatibility complex. Circulation 1998; 97(12):1124-1128.

178. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA 1998; 280(22):1920-1925.

179. Jensen JB, Sperling B, Severinghaus JW, Lassen NA. Augmented hypoxic cerebral vasodilation in men during 5 days at 3,810 m altitude. J Appl Physiol 1996; 80(4):1214-1218.

180. Levine BD, Yoshimura K, Kobayashi T, Fukushima M, Shibamoto T, Ueda G. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1989; 321(25):1707-1713.

181. Krasney JA. A neurogenic basis for acute altitude illness. Med Sci Sports Exerc 1994; 26(2):195-208.

182. Fulco CS, Rock PB, Cymerman A. Improving athletic performance: is altitude residence or altitude training helpful? Aviat Space Environ Med 2000; 71(2):162-171.

183. Levine BD. Intermittent hypoxic training: fact and fancy. High Alt Med Biol 2002; 3(2):177-193.

184. Dolt KS, Mishra MK, Karar J, Baig MA, Ahmed Z, Pasha MA. cDNA cloning, gene organization and variant specific expression of HIF-1 alpha in high altitude yak (Bos grunniens). Gene 2007; 386(1-2):73-80.

185. Dolt KS, Karar J, Mishra MK, Salim J, Kumar R, Grover SK, Qadar Pasha MA. Transcriptional downregulation of sterol metabolism genes in murine liver exposed to acute hypobaric hypoxia. Biochem Biophys Res Commun 2007; 354(1):148-153.

186. Karar J, Dolt KS, Mishra MK, Arif E, Javed S, Pasha MA. Expression and functional activity of pro-oxidants and antioxidants in murine heart exposed to acute hypobaric hypoxia. FEBS Lett 2007; 581(24):4577-4582.

187. Karar J, Dolt KS, Qadar Pasha MA. Endoplasmic reticulum stress response in murine kidney exposed to acute hypobaric hypoxia. FEBS Lett 2008.

188. Tada Y, Laudi S, Harral J et al. MURINE PULMONARY RESPONSE TO CHRONIC HYPOXIA IS STRAIN SPECIFIC. Exp Lung Res 2008; 34(6):313-323.

189. Heinicke K, Prommer N, Cajigal J, Viola T, Behn C, Schmidt W. Long-term exposure to intermittent hypoxia results in increased hemoglobin mass, reduced plasma volume, and elevated erythropoietin plasma levels in man. Eur J Appl Physiol 2003; 88(6):535-543.

190. Katayama K, Sato Y, Ishida K, Mori S, Miyamura M. The effects of intermittent exposure to hypoxia during endurance exercise training on the

ventilatory responses to hypoxia and hypercapnia in humans. Eur J Appl Physiol Occup Physiol 1998; 78(3):189-194.

191. Katayama K, Fujita H, Sato K, Ishida K, Iwasaki K, Miyamura M. Effect of a repeated series of intermittent hypoxic exposures on ventilatory response in humans. High Alt Med Biol 2005; 6(1):50-59.

192. Rodriguez FA, Ventura JL, Casas M et al. Erythropoietin acute reaction and haematological adaptations to short, intermittent hypobaric hypoxia. Eur J Appl Physiol 2000; 82(3):170-177.

193. Huang J, Tamisier R, Ji E, Tong J, Weiss WJ. Chronic intermittent hypoxia modulates nNOS mRNA and protein expression in the rat hypothalamus. Respir Physiol Neurobiol 2007; 158(1):30-38.

194. Nanduri J, Nanduri RP. Cellular mechanisms associated with intermittent hypoxia. Essays Biochem 2007; 43:91-104.

195. Semenza GL, Shimoda LA, Prabhakar NR. Regulation of gene expression by HIF-1. Novartis Found Symp 2006; 272:2-8.

196. Semenza GL, Prabhakar NR. HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 2007; 9(9):1391-1396.

197. Deindl E, Kolar F, Neubauer E, Vogel S, Schaper W, Ostadal B. Effect of intermittent high altitude hypoxia on gene expression in rat heart and lung. Physiol Res 2003; 52(2):147-157.

198. Zhou D, Wang J, Zapala MA, Xue J, Schork NJ, Haddad GG. Gene expression in mouse brain following chronic hypoxia: role of sarcospan in glial cell death. Physiol Genomics 2008; 32(3):370-379.

199. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822):860-921.

200. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001; 291(5507):1304-1351.

201. Brem RB, Yvert G, Clinton R, Kruglyak L. Genetic dissection of transcriptional regulation in budding yeast. Science 2002; 296(5568):752-755.

202. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, Spielman RS. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003; 33(3):422-425.

203. Monks SA, Leonardson A, Zhu H et al. Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 2004; 75(6):1094-1105.

204. Schadt EE, Monks SA, Drake TA et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422(6929):297-302.

205. Jansen RC, Nap JP. Genetical genomics: the added value from segregation. Trends Genet 2001; 17(7):388-391.

206. Li J, Burmeister M. Genetical genomics: combining genetics with gene expression analysis. Hum Mol Genet 2005; 14 Spec No. 2:R163-R169.

207. The International HapMap Project. Nature 2003; 426(6968):789-796.

208. A haplotype map of the human genome. Nature 2005; 437(7063):1299-1320.

209. Zhu M, Zhao S. Candidate gene identification approach: progress and challenges. Int J Biol Sci 2007; 3(7):420-427.

210. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002; 3(5):391-397.

211. Armitage P, Berry G: Statistical methods in medical research. Oxford, Blackwell Scientific Publications, 1987.

212. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997; 53(4):1253-1261.

213. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411(6837):599-603.

214. Rioux JD, Daly MJ, Silverberg MS et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29(2):223-228.

215. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59(Pt 1):97-105.

216. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33(2):177-182.

217. Curtis D. Genetic dissection of complex traits15. Nat Genet 1996; 12(4):356-358.

218. Abecasis GR, Noguchi E, Heinzmann A et al. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 2001; 68(1):191-197.

219. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265(5181):2037-2048.

220. Jorde LB. Linkage disequilibrium as a gene-mapping tool. Am J Hum Genet 1995; 56(1):11-14.

221. Hastbacka J, de la CA, Kaitila I, Sistonen P, Weaver A, Lander E. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet 1992; 2(3):204-211.

222. Jorde LB, Watkins WS, Carlson M, Groden J, Albertsen H, Thliveris A, Leppert M. Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region. Am J Hum Genet 1994; 54(5):884-898.

223. Jorde LB, Watkins WS, Viskochil D, O'Connell P, Ward K. Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping. Am J Hum Genet 1993; 53(5):1038-1050.

224. Watkins WS, Zenger R, O'Brien E, Nyman D, Eriksson AW, Renlund M, Jorde LB. Linkage disequilibrium patterns vary with chromosomal location: a case study from the von Willebrand factor region. Am J Hum Genet 1994; 55(2):348-355.

225. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29(2):311-322.

226. Rutherford PA. Genetic influences in human hypertension. J Hypertens 2003; 21(1):19-22.

227. Gupta R, Sharma AK. Prevalence of hypertension and subtypes in an Indian rural population: clinical and electrocardiographic correlates. J Hum Hypertens 1994; 8(11):823-829.

228. Gupta R, Guptha S, Gupta VP, Prakash H. Prevalence and determinants of hypertension in the urban population of Jaipur in western India. J Hypertens 1995; 13(10):1193-1200.

229. Gupta R, Sharma AK, Gupta VP, Bhatnagar S, Rastogi S, Deedwania PC. Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population. J Hum Hypertens 2003; 17(8):535-540.

230. Salt consumption pattern in India: Delhi India, Indian Council of Medical Research, 1996.

231. Sealey JE, Laragh JH: The rennin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis.; in: Laragh JH, Brenner BM, (eds): New York, Raven Press, 1990, pp 1287-1317.

232. Niu T, Xu X, Cordell HJ, Rogus J, Zhou Y, Fang Z, Lindpaintner K. Linkage analysis of candidate genes and gene-gene interactions in chinese hypertensive sib pairs. Hypertension 1999; 33(6):1332-1337.

233. DeWan AT, Arnett DK, Atwood LD, Province MA, Lewis CE, Hunt SC, Eckfeldt J. A genome scan for renal function among hypertensives: the HyperGEN study. Am J Hum Genet 2001; 68(1):136-144.

234. Xu X, Rogus JJ, Terwedow HA et al. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet 1999; 64(6):1694-1701.

235. Kotchen TA, Broeckel U, Grim CE et al. Identification of hypertension-related QTLs in African American sib pairs. Hypertension 2002; 40(5):634-639.

236. Sharma R. India's doctors issue new hypertension guidelines. BMJ 322[7281], 258. 3-2-2001. BMJ Publishing Group. Ref Type: Magazine Article

237. Ward R: Familial aggregation and genetic epidemiology of blood pressure.; in: Laragh JH, Brenner BM, (eds): New York, Raven Press Ltd, 1990, pp 81-100.

238. MacGregor GA, Markandu ND, Roulston JE, Jones JC, Morton JJ. Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature 1981; 291(5813):329-331.

239. Schmidt S, van H, I, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993; 11(4):345-348.

240. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992; 1(1):72-75.

241. Barley J, Blackwood A, Miller M et al. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 1996; 10(1):31-35.

242. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994; 7(8):759-762.

243. Rotimi C, Morrison L, Cooper R et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994; 24(5):591-594.

244. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93(3):1285-1287.

245. Gainer JV, Hunley TE, Kon V, Nadeau JH, Muldowney JA, III, Brown NJ. Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variant. Biochem Mol Biol Int 1997; 43(1):227-231.

246. Araujo MA, Goulart LR, Cordeiro ER, Gatti RR, Menezes BS, Lourenco C, Silva HD. Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int J Cardiol 2005; 103(1):27-32.

247. Bala M, Gupta S, Pasha MA. Angiotensin-converting enzyme assay optimization: influence of various buffers and their concentrations. Clin Biochem 2000; 33(8):687-689.

248. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3):1215.

249. Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997; 52(2):71-76.

250. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among

estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001; 69(1):138-147.

251. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21(2):263-265.

252. Nejatizadeh A, Kumar R, Stobdan T et al. Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic Biol Med 2008; 44(11):1912-1918.

253. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74(1):106-120.

254. Keavney B, McKenzie CA, Connell JM et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998; 7(11):1745-1751.

255. Forrester T, Farlane-Anderson N, Bennett FI et al. The angiotensin converting enzyme and blood pressure in Jamaicans. Am J Hypertens 1997; 10(5 Pt 1):519-524.

256. Cooper RS, Guo X, Rotimi CN, Luke A, Ward R, Adeyemo A, Danilov SM. Heritability of angiotensin-converting enzyme and angiotensinogen: A comparison of US blacks and Nigerians. Hypertension 2000; 35(5):1141-1147.

257. McKenzie CA, Julier C, Forrester T et al. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 1995; 57(6):1426-1435.

258. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359(6396):641-644.

259. Harrap SB, Davidson HR, Connor JM et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21(4):455-460.

260. Chiang FT, Chern TH, Lai ZP, Tseng CD, Hsu KL, Lo HM, Tseng YZ. Age- and gender-dependent association of the angiotensin-converting enzyme gene with essential hypertension in a Chinese population. J Hum Hypertens 1996; 10(12):823-826.

261. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesaniemi YA, Savolainen MJ. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996; 28(6):1070-1075.

262. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17(1):9-17.

263. Jiang Z, Zhao W, Yu F, Xu G. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Chin Med J (Engl ) 2001; 114(12):1249-1251.

264. Szombathy T, Szalai C, Katalin B, Palicz T, Romics L, Csaszar A. Association of angiotensin II type 1 receptor polymorphism with resistant essential hypertension. Clin Chim Acta 1998; 269(1):91-100.

265. Takami S, Katsuya T, Rakugi H et al. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 1998; 11(3 Pt 1):316-321.

266. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 1997; 15(12 Pt 1):1385-1388.

267. Jeunemaitre X, Inoue I, Williams C et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60(6):1448-1460.

268. Sato N, Katsuya T, Nakagawa T et al. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci 2000; 68(3):259-272.

269. Tsai CT, Fallin D, Chiang FT et al. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 2003; 41(1):9-15.

270. Williams SM, Addy JH, Phillips JA, III et al. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000; 36(1):2-6.

271. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002; 34(2):88-95.

272. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: design and analysis issues. Mutat Res 2005; 573(1-2):54-69.

273. Moore JH, Ritchie MD. STUDENTJAMA. The challenges of whole-genome approaches to common diseases. JAMA 2004; 291(13):1642-1643.

274. Millstein J, Conti DV, Gilliland FD, Gauderman WJ. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 2006; 78(1):15-27.

275. Martin ER, Ritchie MD, Hahn L, Kang S, Moore JH. A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genet Epidemiol 2006; 30(2):111-123.

276. Oelz O, Maggiorini M, Ritter M, Noti C, Waber U, Vock P, Bartsch P. Prevention and treatment of high altitude pulmonary edema by a calcium channel blocker. Int J Sports Med 1992; 13 Suppl 1:S65-S68.

277. Maggiorini M, Melot C, Pierre S et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001; 103(16):2078-2083.

278. Kawashima A, Kubo K, Kobayashi T, Sekiguchi M. Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol 1989; 67(5):1982-1989.

279. Li YY, Luo DC, Xiao Q. [Clinical significance of changes in plasma renin-angiotensin aldosterone system in patients with high altitude pulmonary edema]. Zhonghua Nei Ke Za Zhi 1993; 32(4):232-234.

280. Milledge JS, Catley DM, Ward MP, Williams ES, Clarke CR. Renin-aldosterone and angiotensin-converting enzyme during prolonged altitude exposure. J Appl Physiol 1983; 55(3):699-702.

281. Woods DR, Pollard AJ, Collier DJ et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med 2002; 166(3):362-366.

282. Dehnert C, Weymann J, Montgomery HE et al. No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 2002; 34(12):1928-1933.

283. Rankinen T, Gagnon J, Perusse L et al. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol 2000; 279(1):H368-H374.

284. Bae JS, Kang BY, Lee KO, Lee ST. Genetic variation in the renin-angiotensin system and response to endurance training. Med Princ Pract 2007; 16(2):142-146.

285. Weiss J, Haefeli WE, Gasse C et al. Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway. High Alt Med Biol 2003; 4(3):355-366.

286. Sartori C, Allemann Y, Trueb L, Lepori M, Maggiorini M, Nicod P, Scherrer U. Exaggerated pulmonary hypertension is not sufficient to trigger high-altitude pulmonary oedema in humans. Schweiz Med Wochenschr 2000; 130(11):385-389.

287. Qi Y, Niu W, Zhu T, Zhou W, Qiu C. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol 2008; 23(2):143-152.

288. Kumar R, Pasha Q, Khan AP, Gupta V. Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema. Aviat Space Environ Med 2004; 75(11):981-983.

289. Clark AG. Inference of haplotypes from PCR-amplified samples of diploid populations. Mol Biol Evol 1990; 7(2):111-122.

290. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12(5):921-927.

291. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68(4):978-989.

292. Zhang S, Pakstis AJ, Kidd KK, Zhao H. Comparisons of two methods for haplotype reconstruction and haplotype frequency estimation from population data. Am J Hum Genet 2001; 69(4):906-914.

293. O'Connor T, Dubowitz G, Bickler PE. Pulse oximetry in the diagnosis of acute mountain sickness. High Alt Med Biol 2004; 5(3):341-348.

294. Mazzuero G. [Altitude and the autonomic nervous system]. Ital Heart J Suppl 2001; 2(8):845-849.

295. Bigham AW, Kiyamu M, Leon-Velarde F, Parra EJ, Rivera-Ch M, Shriver MD, Brutsaert TD. Angiotensin-converting enzyme genotype and arterial oxygen saturation at high altitude in peruvian quechua. High Alt Med Biol 2008; 9(2):167-178.

296. Diet F, Graf C, Mahnke N et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes. Eur J Clin Invest 2001; 31(10):836-842.

297. Amir O, Amir R, Yamin C et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol 2007; 92(5):881-886.

298. Alvarez R, Terrados N, Ortolano R et al. Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 2000; 82(1-2):117-120.

299. Rhode D, Haiying Z, Madsen DB, Xing G, Jeffrey Brantingham P, Haizhou M, Olsen JW. Epipaleolithic/early Neolithic settlements at Qinghai Lake, western China. Journal of Archaeological Science 2007; 34(4):600-612.

300. Denell RW, Rendell HM, Hialwood. Late Pliocene artifacts from northern Pakistan. Curr Antropol 1988; 29:495-498.

301. Gayden T, Cadenas AM, Regueiro M et al. The himalayas as a directional barrier to gene flow. Am J Hum Genet 2007; 80(5):884-894.

302. Cann RL. Genetic clues to dispersal in human populations: retracing the past from the present. Science 2001; 291(5509):1742-1748.

303. Gibbons A. Out of Africa--at last? Science 1995; 267(5202):1272-1273.

304. Cavalli-Sforza LL. Genes, peoples, and languages. Proc Natl Acad Sci U S A 1997; 94(15):7719-7724.

305. Kayser M, Brauer S, Stoneking M. A genome scan to detect candidate regions influenced by local natural selection in human populations. Mol Biol Evol 2003; 20(6):893-900.

306. Cavalli-Sforza LL. Population structure and human evolution. Proc R Soc Lond B Biol Sci 1966; 164(995):362-379.

307. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4(4):406-425.

308. Perna NT, Batzer MA, Deininger PL, Stoneking M. Alu insertion polymorphism: a new type of marker for human population studies. Hum Biol 1992; 64(5):641-648.

309. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet 2002; 3(5):370-379.

310. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996; 27(1):62-66.

311. Petrovic D, Peterlin B. Pharmacogenomic considerations of the insertion/deletion gene polymorphism of the angiotensin I-converting enzyme and coronary artery disease. Curr Vasc Pharmacol 2004; 2(3):271-279.

312. Nakai K, Itoh C, Miura Y et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90(5):2199-2202.

313. Slowik A, Turaj W, Dziedzic T et al. DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology 2004; 63(2):359-361.

314. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90(6):2622-2628.

315. Pontremoli R, Ravera M, Viazzi F et al. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension. Kidney Int 2000; 57(2):561-569.

316. Yoshida H, Mitarai T, Kawamura T et al. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995; 96(5):2162-2169.

317. Apte CV. Pulmonary artery pressure in Ladakhi men on exposure to acute hypoxia after a stay at sea level. Indian J Physiol Pharmacol 2004; 48(3):321-328.

318. Thomas DC, Witte JS. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 2002; 11(6):505-512.

319. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361(9357):598-604.

320. Ziv E, Burchard EG. Human population structure and genetic association studies. Pharmacogenomics 2003; 4(4):431-441.

321. Knowler WC, Williams RC, Pettitt DJ, Steinberg AG. Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet 1988; 43(4):520-526.

322. Bhasin V. Ecology and Health: A Study Among Tribals of Ladakh. Stud Tribes Tribals 2005; 3(1):1-13.

323. Wirth T, Wang X, Linz B et al. Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A 2004; 101(14):4746-4751.

324. Bhasin V: Transhumants of Himalaya: Changpas of Ladakh, Goddis of Himachal Pradesh and Bhutias of Sikkim. Delhi, Delhi: Kamla-Raj Enterprises, 1996.

325. Bhasin V. Brok-pa of Ladakh. A case of adaptation to habitat. J Hum Ecol 1992; 3:81.

326. Roychoudhury AK, Nei M. Genetic relationships between Indians and their neighboring populations. Hum Hered 1985; 35(4):201-206.

327. Kumar V, Reddy AN, Babu JP et al. Y-chromosome evidence suggests a common paternal heritage of Austro-Asiatic populations. BMC Evol Biol 2007; 7:47.

328. Pasha MA, Khan AP, Kumar R et al. Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci 2002; 27(1 Suppl 1):67-70.

329. Garcia-Obregon S, fonso-Sanchez MA, Perez-Miranda AM, Vidales C, Arroyo D, Pena JA. Genetic position of Valencia (Spain) in the Mediterranean basin according to Alu insertions. Am J Hum Biol 2006; 18(2):187-195.

330. Nei M, Tajima F, Tateno Y. Accuracy of estimated phylogenetic trees from molecular data. II. Gene frequency data. J Mol Evol 1983; 19(2):153-170.

331. Battilana J, Fagundes NJ, Heller AH et al. Alu insertion polymorphisms in Native Americans and related Asian populations. Ann Hum Biol 2006; 33(2):142-160.

332. Yunusbayev B, Kutuev I, Khusainova R, Guseinov G, Khusnutdinova E. Genetic structure of Dagestan populations: a study of 11 Alu insertion polymorphisms. Hum Biol 2006; 78(4):465-476.

333. Xiao FX, Yotova V, Zietkiewicz E et al. Human X-chromosomal lineages in Europe reveal Middle Eastern and Asiatic contacts. Eur J Hum Genet 2004; 12(4):301-311.

334. Di BG, Erguven A, Stenico M, Castri L, Bertorelle G, Togan I, Barbujani G. DNA diversity and population admixture in Anatolia. Am J Phys Anthropol 2001; 115(2):144-156.

335. Macaulay V, Hill C, Achilli A et al. Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes. Science 2005; 308(5724):1034-1036.

336. Torroni A, Miller JA, Moore LG, Zamudio S, Zhuang J, Droma T, Wallace DC. Mitochondrial DNA analysis in Tibet: implications for the origin of the Tibetan population and its adaptation to high altitude. Am J Phys Anthropol 1994; 93(2):189-199.

337. Brantingham PJ, Haizhou MA, Olsen JW, Xing GAO, Madsen DB, Rhode DE. Speculation on the timing and nature of Late Pleistocene hunter-gatherer colonization of the Tibetan Plateau. Chinese Science Bulletin 2003; 48(14):1510-1516.

338. Kapoor S, Kapoor AK. Body structure and respiratory efficiency among high altitude Himalayan populations. Coll Antropol 2005; 29(1):37-43.

339. Rajput C, Arif E, Vibhuti A et al. Predominance of interaction among wild-type alleles of CYP11B2 in Himalayan natives associates with high-altitude adaptation. Biochem Biophys Res Commun 2006; 348(2):735-740.

340. Gadgil M, Shambu PUV, Joshi NV, atil S, anoharan S: The Indian human heritage; Hyderabad, Hyderabad: University Press, 1997, p 1903.

341. Majumder PP, Roy B, Banerjee S et al. Human-specific insertion/deletion polymorphisms in Indian populations and their possible evolutionary implications. Eur J Hum Genet 1999; 7(4):435-446.

342. Qamar R, Ayub Q, Khaliq S, Mansoor A, Karafet T, Mehdi SQ, Hammer MF. African and Levantine origins of Pakistani YAP+ Y chromosomes. Hum Biol 1999; 71(5):745-755.

343. Mansoor A, Mazhar K, Khaliq S et al. Investigation of the Greek ancestry of populations from northern Pakistan. Hum Genet 2004; 114(5):484-490.

344. The Indian Genome Variation database (IGVdb): a project overview. Hum Genet 2005; 118(1):1-11.

345. Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet 2008; 87(1):3-20.

346. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002; 296(5576):2225-2229.

347. Frazer KA, Ballinger DG, Cox DR et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449(7164):851-861.

348. Peltonen L. Identification of Disease Genes in Genetic Isolates. Methods 1996; 9(1):129-135.

349. Kristiansson K, Naukkarinen J, Peltonen L. Isolated populations and complex disease gene identification. Genome Biol 2008; 9(8):109.

350. Dunning AM, Durocher F, Healey CS et al. The extent of linkage disequilibrium in four populations with distinct demographic histories. Am J Hum Genet 2000; 67(6):1544-1554.

351. Tishkoff SA, Dietzsch E, Speed W et al. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 1996; 271(5254):1380-1387.

352. Ding K, Kullo IJ. Molecular evolution of 5' flanking regions of 87 candidate genes for atherosclerotic cardiovascular disease. Genet Epidemiol 2006; 30(7):557-569.

353. Freedman ML, Reich D, Penney KL et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004; 36(4):388-393.

354. Sabeti PC, Reich DE, Higgins JM et al. Detecting recent positive selection in the human genome from haplotype structure. Nature 2002; 419(6909):832-837.

355. Stephens JC, Reich DE, Goldstein DB et al. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 1998; 62(6):1507-1515.

356. Nakajima T, Wooding S, Sakagami T et al. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 2004; 74(5):898-916.

357. Dzau VJ, Mukoyama M, Pratt RE. Molecular biology of angiotensin receptors: target for drug research? J Hypertens Suppl 1994; 12(2):S1-S5.

358. Oro C, Qian H, Thomas WG. Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol Ther 2007; 113(1):210-226.

359. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999; 33(2):613-621.

360. Nalogowska-Glosnicka K, Lacka BI, Zychma MJ et al. Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. Med Sci Monit 2000; 6(3):523-529.